Jing W, Qin L, Zhang XH, Pan F, Ren RR, Li Y, Zhang Y, Peng LH, Wang ZK, Zhang XL. Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors. World J Gastroenterol 2026; 32(28): 121267 [DOI: 10.3748/wjg.121267]
Andrzej S Tarnawski, MD, PhD, Professor
August 11, 2026, 09:06
This study evaluates a simplified screening strategy for colorectal cancer by combining fecal calprotectin (FC) with a high-sensitivity quantitative fecal immunochemical test (hs-qFIT). The reported sensitivity of 87.5% for colorectal cancer suggests that this combined approach may improve noninvasive detection and could be valuable for the follow-up of low-risk patients.
Please LOGIN to submit a new comment.